BeiGene vs Cognos Therapeutics
BeiGene vs Cognos Therapeutics, compared side by side on 9 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BeiGene is on 64/100 and Cognos Therapeutics on 8/100.
Where each one leads
BeiGene
- our overall score: 64/100 against 8/100
Cognos Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BeiGene | Cognos Therapeutics |
|---|---|---|
| What it is | A global oncology company developing and commercializing innovative cancer treatments. | Cognos Therapeutics is developing a novel therapeutic approach for neurodegenerative diseases. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2010 | Not published |
| Headquarters | Cambridge, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | BeiGene | Cognos Therapeutics |
|---|---|---|
| Open roles | 99 | Not published |
| Total funding | $358M | Not published |
| Latest round | Secondary Offering | Not published |
| Valuation | $15B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BeiGene | Cognos Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 8/100 |
| Traction | 40/100 | Not published |
| Team | 30/100 | Not published |
| Search visibility | 17/100 | 10/100 |
| Quality | 88/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 69/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BeiGene | Cognos Therapeutics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
BeiGene vs Cognos Therapeutics: common questions
Which is better, BeiGene or Cognos Therapeutics?
On our 0-100 score BeiGene rates higher (64/100 against 8/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 9 data points above: read the rows that match what you are buying for.
How do BeiGene and Cognos Therapeutics compare on the numbers?
BeiGene leads on our overall score (64/100 against 8/100).
Read the full BeiGene review and pricing or the Cognos Therapeutics review and pricing. You can also browse other BeiGene alternatives we track.